[go: up one dir, main page]

RU2021109304A - MEANS FOR EXTERNAL USE WITH ANTI-VIRAL ACTION - Google Patents

MEANS FOR EXTERNAL USE WITH ANTI-VIRAL ACTION Download PDF

Info

Publication number
RU2021109304A
RU2021109304A RU2021109304A RU2021109304A RU2021109304A RU 2021109304 A RU2021109304 A RU 2021109304A RU 2021109304 A RU2021109304 A RU 2021109304A RU 2021109304 A RU2021109304 A RU 2021109304A RU 2021109304 A RU2021109304 A RU 2021109304A
Authority
RU
Russia
Prior art keywords
agent according
alloferon
agent
arginine
hyaluronic acid
Prior art date
Application number
RU2021109304A
Other languages
Russian (ru)
Other versions
RU2819719C2 (en
Inventor
Герман Петрович Беккер
Борис Алексеевич Никонов
Original Assignee
Герман Петрович Беккер
Filing date
Publication date
Application filed by Герман Петрович Беккер filed Critical Герман Петрович Беккер
Publication of RU2021109304A publication Critical patent/RU2021109304A/en
Application granted granted Critical
Publication of RU2819719C2 publication Critical patent/RU2819719C2/en

Links

Claims (7)

1. Средство для наружного применения, обладающее противовирусным действием, преимущественно против герпеса и ВПЧ, включающее гиалуроновую кислоту, отличающееся тем, что дополнительно содержит аргинин, а в качестве активного противовирусного компонента оно содержит 0,010 % пептида Аллоферон или его комплекса с цинком при следующих соотношениях компонентов, мас.%:1. An external agent with an antiviral effect, mainly against herpes and HPV, including hyaluronic acid, characterized in that it additionally contains arginine, and as an active antiviral component it contains 0.010% of the Alloferon peptide or its complex with zinc in the following ratios of components , wt.%: пептид Аллоферон или его комплекс с цинкомpeptide Alloferon or its complex with zinc 0,010.01 Гиалуроновая кислотаHyaluronic acid 0,5-1,00.5-1.0 АргининArginine 0,050.05 ОсноваThe foundation до 100,0up to 100.0
2. Средство по п.1, отличающееся тем, что дополнительно содержит 0,1 - 0,4% токоферол ацетата.2. The agent according to claim 1, characterized in that it additionally contains 0.1 - 0.4% tocopherol acetate. 3. Средство по п.1, отличающееся тем, что дополнительно в качестве противовоспалительного компонента оно содержит 0,03% супероксиддисмутазы.3. The agent according to claim 1, characterized in that it additionally contains 0.03% superoxide dismutase as an anti-inflammatory component. 4. Средство по п.1, отличающееся тем, что в его состав в качестве активных компонентов входят биологически активные растительные экстракты.4. The agent according to claim 1, characterized in that it contains biologically active plant extracts as active components. 5. Средство по п.1, отличающееся тем, что средство получено в виде мази, в которой на 10 мг аллоферона берут: ланолина безводного 23 г, вазелина медицинского 35 г, глицерина 6 г, пропилпарабена 0,1 г, аргинина 50 мг, гиалуроновой кислоты 1 г, полиэтиленгликоля 6 г.5. The agent according to claim 1, characterized in that the agent is obtained in the form of an ointment in which for 10 mg of alloferon they take: anhydrous lanolin 23 g, medical vaseline 35 g, glycerin 6 g, propylparaben 0.1 g, arginine 50 mg, hyaluronic acid 1 g, polyethylene glycol 6 g. 6. Средство по п.1, отличающееся тем, что средство получено в виде крема, в котором на 10 мг аллоферона берут: глицерина 15,8 г, бутиленгликоля 7,4 г, природного жира 15,2 г, цетилового спирта 4,2 г, стеариновой кислоты 1 г, сквалана 3 г, сорбитан стеарата 1 г, 1,2-пропандиола 0,3 г, пропилпарабена 0,1 г.6. The agent according to claim 1, characterized in that the agent is obtained in the form of a cream, in which 10 mg of alloferon is taken: glycerol 15.8 g, butylene glycol 7.4 g, natural fat 15.2 g, cetyl alcohol 4.2 g, stearic acid 1 g, squalane 3 g, sorbitan stearate 1 g, 1,2-propanediol 0.3 g, propylparaben 0.1 g.
RU2021109304A 2021-04-05 Agent for external use with antiviral action RU2819719C2 (en)

Publications (2)

Publication Number Publication Date
RU2021109304A true RU2021109304A (en) 2022-10-05
RU2819719C2 RU2819719C2 (en) 2024-05-23

Family

ID=

Similar Documents

Publication Publication Date Title
US8318219B2 (en) Isolated extract of walnuts, method for its obtention and its use
US20080260656A1 (en) Ungual/periungual compositions comprising morpholine compounds and water-soluble film-forming agents
EP1641459B1 (en) Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis
US9770475B2 (en) Compositions for the treatment of peripheral ulcers of various origins
US4866067A (en) 6-piperidino-2,4-diaminopyrimidine-3-oxide salt of 3-carboxypyridine n-oxide and topical, related compositions
EP1448186B1 (en) Medicament for the treatment of viral skin and tumour diseases
RU2021109304A (en) MEANS FOR EXTERNAL USE WITH ANTI-VIRAL ACTION
US7494672B2 (en) Use of guaiac wood for treating inflammation of the skin
US6699512B2 (en) Hypericum perforatum l. oleoresin, procedure for obtaining it and uses of it
US10149877B2 (en) Compositions for the treatment of peripheral ulcers of various origins
Imwidthaya et al. A study of dermatophytoses in Bangkok (Thailand)
CN111568918A (en) Gel composition for treating inflammatory acne and preparation method thereof
WO2020186683A1 (en) Application of quercetin in preparation of drug for prevention and treatment of drug-induced liver injury
WO2006063402A1 (en) Therapeutic compositions based on extracts of plants from the genus plumeria (frangipani)
KR102481125B1 (en) A composition for skin anti-pollution containing a daughter-in-law navel extract
CN111568921A (en) Novel selenium preparation formula for promoting recovery of patients with coronavirus and preparation method thereof
CN112206316B (en) Medical ray protective agent and preparation method thereof
RU2021116645A (en) ANTI-VIRAL AND ANTI-INFLAMMATORY ACTION IN THE FORM OF FOAM AEROSOL ON THE BASIS OF ALLOFERON AND ITS APPLICATION
RU2709524C1 (en) Wound healing agent
US12090133B2 (en) Topical composition
US10166235B2 (en) Kinetin/zeatin topical formulation
RU2024109492A (en) A pharmaceutical composition in the form of a phytogel for the treatment of wounds of various etiologies based on extracts of purple echinacea, medicinal burnet, white cinquefoil and round-leaved wintergreen
RU2306137C1 (en) Preparation for preventing and treating influenza
RU2008107117A (en) Plant Extract Alhagi pseudalhagi, pharmaceutical and cosmetic compositions thereof, a method for reducing cholesterol and triglycerides in the blood, reducing the oxidation products of lipids, improve microcirculation, antioxidant properties and metabolic processes, improving the condition of skin, promoting collagen formation, wound healing and REDUCE INFLAMMATIONS
CN119055559A (en) Skin care cream for preventing and repairing stretch marks and preparation method thereof